- Home
- TOP vs INMB Comparison
TOP vs INMB Comparison
Compare TOP & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOP | INMB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2M | 37.2M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TOP | INMB |
|---|---|---|
| Price | $1.38 | $1.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 135.2K | ★ 270.3K |
| Earning Date | 01-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.61 | $1.09 |
| 52 Week High | $3.33 | $11.64 |
Technical Indicators
Market Signals| Indicator | TOP | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 76.84 | 58.27 |
| Support Level | $0.98 | $1.37 |
| Resistance Level | $1.54 | $1.52 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 95.92 | 74.63 |
Price Performance
Historical ComparisonAbout TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.